Current and future perspectives of liquid biopsies in genomics-driven oncology

Current and future perspectives of liquid biopsies in genomics-driven oncology

Current and future perspectives of liquid biopsies in genomics-driven oncology, Published online: 08 November 2018; doi:10.1038/s41576-018-0071-5

Liquid biopsies enable non-invasive, longitudinal analysis of tumour components (including circulating tumour cells and circulating tumour DNA) in bodily fluids such as blood. However, their analytical and clinical validity must be rigorously demonstrated before they are adopted for precision oncology.

from Genetics via xlomafota13 on Inoreader https://ift.tt/2zAyRf1
via IFTTT